Short answer
Arcturus Therapeutics Holdings Inc. (ARCT) filed an 8-K current report with the SEC on August 25, 2026 reporting Item 7.01 (Regulation FD Disclosure). ARCT presenting ARCT-810 clinical data in OTC deficiency at the August 25, 2026 SSIM symposium.
Arcturus Therapeutics Holdings Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- ARCT presenting ARCT-810 clinical data in OTC deficiency at the August 25, 2026 SSIM symposium
- Poster covers dietary intake and biochemical outcomes in adolescents and adults
- Additional data and regulatory plan expected later this quarter, creating a near-term clinical catalyst
- ARCT-810 progress could clarify the program’s development path and future regulatory milestones
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Arcturus Therapeutics Holdings Inc. 8-K filings
Get the next ARCT 8-K as it lands
Follow ARCT for push alerts, or ask the research agent what this filing means.